SPI
18.404,03
PKT
-95,21
PKT
-0,51
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.07.19 | Holcim overweight | JP Morgan Chase & Co. | |
| 31.07.19 | UBS buy | Deutsche Bank AG | |
| 31.07.19 | UBS buy | UBS AG | |
| 31.07.19 | Holcim Neutral | UBS AG | |
| 31.07.19 | Swiss Re Sell | UBS AG | |
| 31.07.19 | UBS buy | Goldman Sachs Group Inc. | |
| 31.07.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 31.07.19 | Swiss Re Sector Perform | RBC Capital Markets | |
| 31.07.19 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 31.07.19 | UBS Neutral | JP Morgan Chase & Co. | |
| 31.07.19 | Holcim Neutral | Goldman Sachs Group Inc. | |
| 30.07.19 | Swiss Re Outperform | Credit Suisse Group | |
| 30.07.19 | Roche buy | Goldman Sachs Group Inc. | |
| 29.07.19 | Nestlé Hold | HSBC | |
| 29.07.19 | Novartis Neutral | UBS AG | |
| 29.07.19 | Nestlé buy | UBS AG | |
| 29.07.19 | Nestlé buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 29.07.19 | Nestlé buy | Deutsche Bank AG | |
| 29.07.19 | Nestlé buy | Goldman Sachs Group Inc. | |
| 29.07.19 | Nestlé overweight | Barclays Capital | |
| 29.07.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.07.19 | Nestlé Underperform | Credit Suisse Group | |
| 26.07.19 | Nestlé overweight | JP Morgan Chase & Co. | |
| 26.07.19 | Nestlé buy | Baader Bank | |
| 26.07.19 | Nestlé buy | UBS AG | |
| 26.07.19 | Nestlé market-perform | Bernstein Research | |
| 26.07.19 | Nestlé overweight | JP Morgan Chase & Co. | |
| 26.07.19 | Nestlé buy | Jefferies & Company Inc. | |
| 26.07.19 | Roche buy | Deutsche Bank AG | |
| 26.07.19 | Nestlé overweight | Morgan Stanley | |
| 26.07.19 | Nestlé overweight | Barclays Capital | |
| 26.07.19 | ABB (Asea Brown Boveri) neutral | Morgan Stanley | |
| 26.07.19 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 26.07.19 | Nestlé buy | Goldman Sachs Group Inc. | |
| 26.07.19 | Roche Neutral | Credit Suisse Group | |
| 26.07.19 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 26.07.19 | Roche buy | UBS AG | |
| 25.07.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. |